Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood… (NCT05582551) | Clinical Trial Compass
RecruitingNot Applicable
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
United States146 participantsStarted 2023-08-02
Plain-language summary
The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.
Who can participate
Age range
7 Years – 17 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with a diagnosis of pediatric cancer (diagnosis at \<18 years of age)
* Treatment including chemotherapy and/or radiation therapy
* Completion of all cancer therapy for at least 6 months and less than 2 years
* Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine
* Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group)
* English speaking
Exclusion Criteria:
* Undergoing active cancer treatment
* Patient under the care of the Late Effects Program at St. Louis Children's Hospital
* Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening.
* Parents and/or patient illiteracy
* No contact with treatment team in the past two years
* In foster care or without a legal guardian
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Percentage of patients with at risk for sensory deficits identified by HPARSS
Timeframe: Through completion of enrollment for all patients (estimated to be 9 months)
2
Percentage of at risk patients who fail the assigned screening test
Timeframe: Through completion of enrollment for all patients (estimated to be 9 months)
3
Percentage of patients in need of referral for screen test results who participate in formal diagnostic testing and/or treatment
Timeframe: Through 1 year after the completion of screening test for all participants (estimated to be 1 year and 9 months)